Written answers
Tuesday, 24 September 2024
Department of Health
Medicinal Products
David Cullinane (Waterford, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
539. To ask the Minister for Health if semaglutide is licensed and approved for use for insulin resistance, weight management or any other purpose in the State; if it is approved or under consideration for reimbursement in any context other than type 2 diabetes; and if he will make a statement on the matter. [37878/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments